← Back to Companies

CereVasc

Medical device company developing minimally invasive treatments for hydrocephalus, a condition caused by abnormal accumulation of cerebrospinal fluid in the brain.

Location
Boston, Massachusetts, USA
Founded
2014
Categories
medical-devices, neurology, hydrocephalus, neurointerventional

Notes

CereVasc is a medical device company developing novel minimally invasive treatments for hydrocephalus, a debilitating neurological condition affecting over one million patients in the United States. The company's eShunt™ System is designed to provide a permanent, minimally invasive solution for cerebrospinal fluid (CSF) drainage.

The eShunt System is an endovascular implant that creates a new pathway for CSF drainage, potentially eliminating the need for traditional surgical shunts that have high failure rates and require multiple revisions.

Team

  • Dan Cote - Chief Executive Officer
  • Maged Amine - Chief Technology Officer
  • Andrew Grande, M.D. - Chief Medical Officer

Additional Research Findings

  • Backed by Bain Capital Life Sciences
  • eShunt™ System for hydrocephalus treatment
  • Minimally invasive endovascular approach
  • Alternative to traditional surgical shunts
  • Focus on reducing shunt revision surgeries
  • Headquarters in Boston, Massachusetts
  • Addressing significant unmet medical need in neurology

Sources